APA

Piñeyro-López A., Pineyro-Garza E., Torres-Alanís O., Reyes-Araiza R., Gómez Silva M., Wacksman N., Rangel R. L., de Lago A., González-de la Parra M. & Namur S. (20060201). Bioavailability of two oral formulations of azithromycin 500 mg: a randomized, open-label, two-period crossover comparison in healthy Mexican adult subjects. : Clinical therapeutics.

Chicago

Piñeyro-López Alfredo, Pineyro-Garza Everardo, Torres-Alanís Oscar, Reyes-Araiza Raúl, Gómez Silva Magdalena, Wacksman Noemí, Rangel Rubén Luján, de Lago Alberto, González-de la Parra Mario and Namur Salvador. 20060201. Bioavailability of two oral formulations of azithromycin 500 mg: a randomized, open-label, two-period crossover comparison in healthy Mexican adult subjects. : Clinical therapeutics.

Harvard

Piñeyro-López A., Pineyro-Garza E., Torres-Alanís O., Reyes-Araiza R., Gómez Silva M., Wacksman N., Rangel R. L., de Lago A., González-de la Parra M. and Namur S. (20060201). Bioavailability of two oral formulations of azithromycin 500 mg: a randomized, open-label, two-period crossover comparison in healthy Mexican adult subjects. : Clinical therapeutics.

MLA

Piñeyro-López Alfredo, Pineyro-Garza Everardo, Torres-Alanís Oscar, Reyes-Araiza Raúl, Gómez Silva Magdalena, Wacksman Noemí, Rangel Rubén Luján, de Lago Alberto, González-de la Parra Mario and Namur Salvador. Bioavailability of two oral formulations of azithromycin 500 mg: a randomized, open-label, two-period crossover comparison in healthy Mexican adult subjects. : Clinical therapeutics. 20060201.